121 related articles for article (PubMed ID: 26577510)
1. Thalidomide for the treatment of chronic refractory pruritus.
Sharma D; Kwatra SG
J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects and management of chronic itch.
Zeidler C; Raap U; Witte F; Ständer S
J Allergy Clin Immunol; 2023 Jul; 152(1):1-10. PubMed ID: 37178730
[TBL] [Abstract][Full Text] [Related]
3. Oral Alitretinoin for Patients with Refractory Prurigo.
Chung BY; Um JY; Kang SY; Jung MJ; Kim JC; Kwak IS; Park CW; Kim HO
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33182351
[No Abstract] [Full Text] [Related]
4. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S; Pereira MP; Zeidler C; Legat FJ; Misery L; Lönndahl L; Bewley AP; Brenaut E; Bobko S; Elberling J; Evers AWM; Garcovich S; Gieler U; Gonçalo M; Kupfer J; Lambert J; Lvov A; Metz M; Michenko A; Papadavid E; Reich A; Savk E; Schneider G; Schut C; Serra-Baldrich E; Ständer HF; Szepietowski JC; Wallengren J; Weisshaar E; Augustin M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38738586
[TBL] [Abstract][Full Text] [Related]
5. Alternative Strategies in Thalassemia: Focus on Thalidomide.
Naithani R; Jeyaraman P; Mahapatra M
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):227-228. PubMed ID: 32425370
[No Abstract] [Full Text] [Related]
6. Gabapentin and pregabalin for the treatment of chronic pruritus.
Matsuda KM; Sharma D; Schonfeld AR; Kwatra SG
J Am Acad Dermatol; 2016 Sep; 75(3):619-625.e6. PubMed ID: 27206757
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide for the treatment of chronic refractory prurigo nodularis.
Aguh C; Kwatra SG; He A; Okoye GA
Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
[TBL] [Abstract][Full Text] [Related]
8. Aprepitant for the Treatment of Chronic Refractory Pruritus.
He A; Alhariri JM; Sweren RJ; Kwatra MM; Kwatra SG
Biomed Res Int; 2017; 2017():4790810. PubMed ID: 29057261
[TBL] [Abstract][Full Text] [Related]
9. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Sarcoidosis.
Wanat KA; Rosenbach M
Clin Chest Med; 2015 Dec; 36(4):685-702. PubMed ID: 26593142
[TBL] [Abstract][Full Text] [Related]
11. Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.
Yosipovitch G; Ständer S; Kerby MB; Larrick JW; Perlman AJ; Schnipper EF; Zhang X; Tang JY; Luger T; Steinhoff M
J Am Acad Dermatol; 2018 May; 78(5):882-891.e10. PubMed ID: 29462657
[TBL] [Abstract][Full Text] [Related]
12. Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
Ko KC; Tominaga M; Kamata Y; Umehara Y; Matsuda H; Takahashi N; Kina K; Ogawa M; Ogawa H; Takamori K
Acta Derm Venereol; 2016 Jun; 96(5):624-9. PubMed ID: 26671728
[TBL] [Abstract][Full Text] [Related]
13. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids for the treatment of chronic pruritus: A review.
Avila C; Massick S; Kaffenberger BH; Kwatra SG; Bechtel M
J Am Acad Dermatol; 2020 May; 82(5):1205-1212. PubMed ID: 31987788
[TBL] [Abstract][Full Text] [Related]
15. Pruritus: Progress toward Pathogenesis and Treatment.
Song J; Xian D; Yang L; Xiong X; Lai R; Zhong J
Biomed Res Int; 2018; 2018():9625936. PubMed ID: 29850592
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
[No Abstract] [Full Text] [Related]
17. Prevalence of prurigo nodularis in the United States.
Whang KA; Mahadevan V; Bakhshi PR; Williams KA; Gabriel S; Chavda R; Kwatra SG
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3240-3241. PubMed ID: 32531481
[No Abstract] [Full Text] [Related]
18. A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus.
Aquino TMO; Luchangco KAC; Sanchez EV; Verallo-Rowell VM
Int J Dermatol; 2020 Aug; 59(8):955-961. PubMed ID: 32459016
[TBL] [Abstract][Full Text] [Related]
19. Inpatient Burden of Prurigo Nodularis in the United States.
Whang KA; Kang S; Kwatra SG
Medicines (Basel); 2019 Aug; 6(3):. PubMed ID: 31405223
[No Abstract] [Full Text] [Related]
20. Itch: From mechanism to (novel) therapeutic approaches.
Yosipovitch G; Rosen JD; Hashimoto T
J Allergy Clin Immunol; 2018 Nov; 142(5):1375-1390. PubMed ID: 30409247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
